Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing Revision: v3.4.1. This is a minor UI/content label update that does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no study content or location details appear to be affected, and the page's core purpose remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page shows a new revision tag added: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedA new Locations section lists study sites by state, including Minnesota and Texas.SummaryDifference0.3%

- Check115 days agoChange DetectedThe page now displays revision v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.